KCT0002179招募中未知
Clinical study evaluates the safety and efficacy of the OA Kneetrac CHANGEUI MEDICAL co., Ltd. for patients with knee joint osteoarthritis
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1) Adults over 20 years old
- •2) Diagnosis: Osteoarthritis of the Knee
- •3) In the anteroposterior x-ray of the knee in a standing position according to the scale Kellgren-Lawrence (K-L) patient received ?, ? grade diagnosis
- •4) The patient has subscribed the informed consent
排除标准
- •1) The patients with lower extremity surgical treatments and cortisone injections for those who receive treatment within the last 3 months. (Steroidal and non-steroidal anti-inflammatory drug treatments, such as drugs does not limit)
- •2) The patients with ligaments injury, knee joint infection, inflammatory joint disease, fibromyalgia, symptoms of nerve root compression in the spine, central nervous system diseases, polyneuropathy, cognitive disorders, etc.
- •3) Principal investigator who is deemed unsuitable for clinical trial participation
研究者
相似试验
进行中（未招募）
4 期
A study to assess the safety and efficacy of Poly-L-lactic acid dermal fillers in the treatment of facial ageingFacial ageingISRCTN66942709Sinclair Pharma142
招募中
不适用
Clinical study to evaluate safety and efficacy of OA Kneetrac (SP1000 ™) of Changmi Medical Co. in patients with degenerative knee arthritisDiseases of the musculo-skeletal system and connective tissueKCT0003907Chonbuk National University Hospital30
已完成
3 期
Clinical Trial of S-Amlodipine , Olmesartan and Hydrochlorothiazide combination tablet in the treatment of HypertensioCTRI/2011/06/001820Emcure Pharmaceuticals Ltd Pune200
未知
3 期
Clinical Study to assess the efficacy and safety of increased dose of TA-650 in patients with Rheumatoid ArthritisRheumatoid ArthritisJPRN-jRCT2080220144Mitsubishi Tanabe Pharma Corporation
已完成
3 期
Clinical Trial of S-Metoprolol , Atorvastatin and Ramipril combination tablet in the treatment of HypertensioCTRI/2011/06/001818Emcure Pharmaceuticals Ltd Pune200